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Infection by herpes simplex virus type 1 (HSV-1) induces a persistent nuclear translocation of NFB. To
identify upstream effectors of NFB and their effect on virus replication, we employed mouse embryo fibroblast
(MEF)-derived cell lines with deletions of either IKK1 or IKK2, the catalytic subunits of the IB kinase (IKK)
complex. Infected MEFs were assayed for virus yield, loss of IB, nuclear translocation of p65, and NFB
DNA-binding activity. Absence of either IKK1 or IKK2 resulted in an 86 to 94% loss of virus yield compared
to that of normal MEFs, little or no loss of IB, and greatly reduced NFB nuclear translocation. Consistent
with reduced virus yield, accumulation of the late proteins VP16 and gC was severely depressed. Infection of
normal MEFs, Hep2, or A549 cells with an adenovirus vector expressing a dominant-negative (DN) IB,
followed by superinfection with HSV, resulted in a 98% drop in virus yield. These results indicate that the
IKK-IB-p65 pathway activates NFB after virus infection. Analysis of NFB activation and virus replication
in control and double-stranded RNA-activated protein kinase-null MEFs indicated that this kinase plays no
role in the NFB activation pathway. Finally, in cells where NFB was blocked because of DNIB expression,
HSV failed to suppress two markers of apoptosis, cell surface Annexin V staining and PARP cleavage. These
results support a model in which activation of NFB promotes efficient replication by HSV, at least in part by
suppressing a host innate response to virus infection.
Cells activate the transcription factor NFB in a wide variety
of situations, including responses to stress-inducing insults
such as UV irradiation and virus infection or in response to
cytokines such as tumor necrosis factor alpha (TNF-). NFB
has an important role in suppression of apoptosis and regulates
the expression of many important antiapoptotic functions (5,
31, 48, 50). NFB, as a p65/p50 heterodimer, is normally se-
questered in the cytoplasm in a complex with inhibitor of B
(IB). IB is targeted for phosphorylation at serine residues
32 and 36, and IB is targeted for phosphorylation at serine
residues 19 and 23 (42, 46, 51), by the multisubunit IB kinase
(IKK) (11, 23, 36, 52, 58). This phosphorylation triggers its
polyubiquitylation and destruction by the 26S proteosome (6,
7, 12), and, as a result, NFB is translocated to the nucleus (14,
57). Key roles for IKK and IB in NFB signaling were dem-
onstrated in studies in which overexpression of a kinase-dead,
trans-dominant form of IKK prevents IB phosphorylation and
inhibits NFB activation (36, 52). IKK is activated by phos-
phorylation mediated by mitogen-activated protein (MAP) ki-
nase kinase kinases (MAP3Ks) MEKK1, -2, or -3 or NFB-
inducing kinase (NIK) (23, 30, 37, 59). Under stress conditions,
the double-stranded RNA-activated protein kinase (PKR) has
been shown to activate NFB through a pathway dependent on
NIK and IKK (57). Distinct roles for the catalytic components
of the IKK have been recognized. IKK appears to play a
major role in transducing signals for NFB activation during
embryonic development (18, 45), while IKK is essential for
cytokine and other stress-induced signaling pathways (10, 27,
29). Besides cytoplasmic roles in the activation of NFB, re-
cent studies have identified IKK and the IKK scaffold protein
IKK/NEMO in direct regulation of NFB-dependent tran-
scription in the nucleus (2, 49, 53). NFB activation is also
dependent on distinct signaling pathways which target p65 for
phosphorylation (32).
The ability of herpes simplex virus type 1 (HSV-1) to acti-
vate NFB has been well documented (1, 15, 40). Beginning at
3 to 5 h postinfection (hpi), HSV-1 induced a strong and
persistent nuclear translocation, increased p50/p65-dependent
DNA binding activity as measured by electrophoretic mobility
shift assay (EMSA), and induced activation of a 3XNFB-
luciferase reporter. Persistent NFB activation required virus
binding and entry as well as de novo infected cell protein
synthesis, including expression of functional viral immediate-
early (IE) protein ICP27. Activation was also accompanied by
increased IKK activity and loss of both IB and IB. Inter-
ference with NFB activation occurred following expression of
a dominant-negative IB (DNIB) containing alanine substi-
tutions for serine residues 32 and 36 normally targeted by IKK.
The resulting substantial reduction in NFB EMSA activity
correlated with a reduction in virus yield. The latter may be
related to the reported role of NFB in preventing HSV-1-
induced apoptosis (15). The foregoing results argue that the
observed persistent NFB activation, rather than being a host
response to virus infection, plays a positive role in the promot-
ing efficient virus replication.
Toll-like receptors (TLRs) and associated downstream sig-
naling components can also mediate activation of NFB (35,
44). While HSV-1 infection stimulated interferon production
in mice by a mechanism dependent on TLR9/MyD88 (20) and
TLR2 mediated an inflammatory response that contributes to
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lethal encephalitis in a murine model of HSV-1 pathogenesis
(22), as yet no direct evidence links TLRs to NFB activation
during HSV-1 infection.
The experiments presented here were designed to more fully
characterize the activation pathway for NFB in HSV-infected
cells and to assess how components of the classical NFB
activation pathway (IKK-IB-p65/p50) contribute to virus
replication. Our approach was to assess virus replication and
markers of NFB activation in mouse embryo fibroblasts
(MEFs) with targeted deletions in key components of the sig-
naling pathway (IKK or IKK) or through overexpression of
a DNIB and to assess HSV replication and the ability of
HSV to suppress markers of apoptosis.
MATERIALS AND METHODS
Viruses and cells. All experiments were performed with the KOS1.1 strain of
HSV-1. Adenovirus vectors expressing a dominant-negative IB (DNIB) or
green fluorescent protein (GFP) were obtained from the Virus Vector Core
Facility at University of North Carolina (UNC)-Chapel Hill. Spontaneously
immortalized mouse embryo fibroblasts derived from normal mice or mice with
targeted deletions in IKK or IKK (26, 27) were obtained form Tal Kafri
(UNC-Chapel Hill). MEFs from normal mice or mice with a targeted deletion of
the double-stranded RNA-activated protein kinase PKR (54) were obtained
from Bryan Williams (Cleveland Clinic). These cell lines as well as A549 cells
were maintained in Dulbecco’s modified Eagle medium (DMEM) supplemented
with 10% fetal bovine calf serum, 100 U of penicillin/ml, 1% streptomycin, and
1% L-glutamine (all from Gibco). Hep2 cells were maintained in minimal essen-
tial medium supplemented as described for DMEM.
Plaque assay. Monolayers of cells in 60-mm-diameter dishes were infected
with HSV at a multiplicity of infection (MOI) of 5, and cells and medium were
harvested at various times postinfection, followed by three cycles of freezing and
thawing. Serial 10-fold dilutions of the lysates were assayed in triplicate on
monolayers of Vero cells in 12-well dishes. After 1 h, monolayers were covered
with DMEM-H containing 2% calf serum and 0.3% methylcellulose. After 3 days
of incubation at 37°C, medium was aspirated from the wells and plaques were
stained with 0.8% crystal violet in 50% ethanol (EtOH).
Preparation of cell extracts and Western blotting. For preparation of whole-
cell extracts, medium was removed and monolayers were rinsed with ice-cold
Dulbecco’s phosphate-buffered saline (PBS). Cells were scraped directly into 1
sodium dodecyl sulfate (SDS) sample buffer (3.85 mM Tris base [(pH 6.8], 9.1%
-mercaptoethanol, 1.82% SDS, 4.6% glycerol, and 0.023% bromophenol blue
[in 100% EtOH]) and denatured by boiling. Cell-equivalent amounts of lysate
were separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE). Frac-
tionated cytoplasmic and nuclear extracts were prepared as described previously
(38). Briefly, cells were collected by trypsinization, spun through a cushion of
bovine calf serum, washed twice in PBS, resuspended in three packed cell
volumes (PCV) of CE buffer (10 mM HEPES, [pH 7.8], 1 mM EDTA, 60 mM
KCl, 1 mM phenylmethylsulfonyl fluoride [PMSF], 0.1% NP-40, 25% glycerol,
0.4 mM NaF, 0.4 mM Na3VO4, 10 M pepstatin, and Complete Protease Inhib-
itor Cocktail [Roche]), and incubated on ice for 10 min. Following a 10-s spin in
a benchtop microcentrifuge, the supernatant was removed and the nuclear pellet
was resuspended in CW buffer (CE buffer without NP-40 or glycerol) and
repelleted. Nuclei were resuspended in 2 PCV of NE buffer (20 mM Tris-HCl
[pH 8.0], 420 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM PMSF, 25%
glycerol, and phosphatase and protease inhibitors as described above). After
incubation on ice for 10 min, nuclei were pelleted at 60,000 rpm at 4°C for 20 min
in a Beckman TLA100.3 rotor. The nuclear extract supernatant was carefully
removed, and aliquots were stored at 80°C.
Equal amounts of protein were transferred to PolyScreen polyvinylidene di-
fluoride (PVDF) membranes (Perkin-Elmer Life Sciences) followed by blocking
in TBST (150 mM NaCl, 20 mM Tris [pH 7.6], 0.05% Tween 20) with 5% milk.
All probing and washing of membranes was done in TBST. Rabbit polyclonal
antibodies for IKK (H-470, sc-7607), IKK (H-744, sc-7218), and IB- (C-21,
sc-371) from Santa Cruz Biotechnology were used at a 1:1,000 dilution overnight
at 4°C per the manufacturer’s instructions. Rabbit polyclonal antibody for p65
(100-4165) was from Rockland and was used at a 1:2,000 dilution for 1 h at room
temperature. Monoclonal antibodies against HSV IE ICP4 (1101) and ICP27
(1119) were purchased from the Rumbaugh-Goodwin Institute for Cancer Re-
search (Plantation, Fla.) and were used at a 1:800 dilution. Polyclonal antibody
for VP16 (Clontech) was used at a 1:5,000 dilution. Polyclonal antibody against
ICP8 (3-83) was a generous gift from David Knipe (Harvard University) and was
used at a 1:1,000 dilution. Polyclonal antibody against gC (R47), used at 1:5,000,
was a generous gift of Gary Cohen (University of Pennsylvania). Rabbit poly-
clonal antibody to PARP (H-250, sc-7150) was used at a 1:1,000 dilution. Goat
anti-rabbit and anti-mouse secondary antibodies were purchased from Amer-
sham Biosciences. The secondary antibody was detected with SuperSignal West
Pico Chemiluminescent substrate agent (Pierce). Autoradiographic films were
scanned, and images were stored as 8-bit grayscale JPEG files. The density of
each band was determined by using Image J (National Institutes of Health).
Relative density values were corrected for average background by subtracting the
density of a blank portion of the film. The corrected values were then used to
calculate fold change relative to the control sample (e.g., the ratio of the mock-
infected cell value to the infected cell value).
EMSA. Preparation of nuclear extracts and mobility shift assays for NFB
were performed as described previously (17, 38, 40). Nuclear extract was incu-
bated with a radiolabeled probe containing a B-binding site, TGGGGATTC
CCCA, in buffer containing 10 mM Tris-HCl (pH 7.9), 50 mM NaCl, 0.5 mM
EDTA, 10% glycerol, 1 mM dithiothreitol, and 2 g of poly(dI-dC) · poly(dI-
dC). Following 20 min of incubation at room temperature, aliquots were frac-
tionated at 4°C on nondenaturing 4% polyacrylamide gels prepared in 0.25
TBE (1 TBE is 10 mM Tris base [pH 8.3], 9 mM boric acid, and 2 mM EDTA).
Gels were then placed on 3MM paper, dried under vacuum and heat, and
exposed to Kodak BMR film at 70°C.
Annexin V staining. Infected Hep2 cells were stained with Annexin V by using
the Vybrant Apoptosis Assay kit #2 (Molecular Probes) per the manufacturer’s
instructions. Briefly, cells were harvest by trypsin treatment and were resus-
pended in DMEM supplemented with 10% fetal bovine calf serum, 100 U of
penicillin/ml, 1% streptomycin, and 1% L-glutamine. Following pelleting, cells
were resuspended at 106/ml in 1 binding buffer followed by addition of 50 l of
Annexin stain/ml and 10 l of propidium iodide (100 g/ml in 1 binding
buffer)/ml. Cells were incubated at room temperature for 15 min, and then 400
l of binding buffer was added for a total volume of 500 l. Stained cells were
kept on ice until Annexin staining was quantified by fluorescence-activated cell
sorter (FACS) analysis.
RESULTS
Both IKK and IKK contribute to virus yield and NFB
activation in HSV-infected cells. The multisubunit IKK com-
plex phosphorylates IB, triggering the latter’s destruction and
subsequent nuclear localization of NFB (14, 57). IKK activity
was reported to increase following HSV infection (1). To de-
termine the importance of IKK catalytic subunits IKK and
IKK on the replication efficiency of HSV-1, we prepared
lysates at 8 hpi from cell lines derived from normal MEFs or
MEFs from embryos with targeted deletions of either IKK or
IKK and assessed the effect of loss of either catalytic com-
ponent of IKK on levels of IB and nuclear translocation of
p65, two markers of NFB activation. The results of Western
blots are presented in Fig. 1A. First, cytoplasmic extracts were
probed for IKK subunits to confirm their presence or absence
in IKKa/ and IKKb/ MEF lines (compare IKK and
IKK in lanes 1 to 3 with 4 to 6 and lanes 7 to 9 with 10 to 12).
IKK and IKK levels were used as loading controls for cyto-
plasmic samples, and PARP was used as a loading control for
nuclear samples. As an assessment of our fractionation proce-
dure, we did not detect IKK or IKK in nuclear lysates or
PARP in the cytoplasm (data not shown). Following infection
or TNF- treatment of wild-type (WT), IKKa/, and
IKKb/ cells, we observed nuclear translocation of p65 (com-
pare lanes 1 to 6 and 7 to 12). Compared to their correspond-
ing mock-infected nuclear samples, increases in nuclear p65
following HSV infection or TNF- treatment were approxi-
mately twofold greater in WT cells than in either of the IKK
knockout cell types. Importantly, infection of WT and
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IKKa/ cells also resulted in two- to threefold reductions in
cytoplasmic p65 compared to that of mock-infected cells, while
no reduction in cytoplasmic p65 was detected in IKKb/ cells
following infection or TNF- treatment. We observed an ap-
parent increase in the total amount of p65 after TNF- treat-
ment of both WT and IKKa/ cells (lanes 3 and 6). Whether
this reflects the ability of this cytokine to activate Sp1 and
transcriptionally activate the p65 promoter (47) is presently
unknown. Quantification by Image J, as described in Materials
and Methods, revealed 29- and 20-fold reductions, respec-
tively, in IB following HSV infection or TNF- treatment of
WT cells. Reductions of IB in IKKa/ cells were 4.4-fold
following HSV infection and 8.7-fold after TNF- treatment.
Consistent with the reduced nuclear translocation of p65 ob-
served in IKKb/ cells, IB was reduced in these cells only
1.3- and 1.1-fold following infection or TNF- treatment.
Filters were also probed for several viral proteins represen-
tative of different kinetic classes. While IE ICP27 levels were
comparable between WT and IKKb/, we observed de-
creased ICP27 accumulation (1.7-fold relative to that of the
WT) in IKKa/ cells. Delayed early (DE) ICP8 accumulation
was comparable in the three cell types (Fig. 1B, lanes 2, 5, and
8). In contrast, accumulation of the L proteins VP16 and gC
was considerably reduced in both knockout cell lines (Fig. 1B,
compare lanes 2 and 5 and lanes 8 and 11). Here we observed
decreases in VP16 of 5- to 6-fold and decreases in gC of 6- to
10-fold, respectively, in IKKa/ and IKKb/ lysates com-
pared to those of WT.
Next, we determined virus yields in cell lines derived from
normal MEFs compared to those of IKKa/ and IKKb/
MEFs. Cultures were harvested at 16 and 24 hpi, and infec-
tious virus was titered on Vero cell monolayers. Results, pre-
sented in Table 1, indicated that both IKK- and IKK-defi-
cient cells were impaired in supporting virus replication,
because virus yield at 24 h was reduced 6- to 28-fold compared
to that of normal cells. Taken together, the results of yield
assays in Table 1 are consistent with results of Western blots
indicating that both IKKa/ and IKKb/ cells were im-
paired in nuclear translocation of p65 and in aspects of late
viral protein accumulation.
We also prepared nuclear extracts from mock-infected,
TNF--treated, and HSV-infected cells and performed EMSA
to determine the effect of loss of IKK or IKK on NFB
DNA-binding activity. In these cell lines we could detect an
abundant NFB complex consisting of p50/p65 under condi-
tions of TNF- treatment or HSV-1 infection (Fig. 2B). Thus,
incubation of lysates with a p65 antibody supershifted a rela-
tively low-mobility complex, while an incubation with a p50
antibody supershifted both the relatively low-mobility complex
and a higher mobility complex. Incubation with an irrelevant
antibody to E2F served as a control. While the ability of p65
and p50 antibodies to shift complexes from TNF--treated
cells appeared quantitative, a small amount of unshifted p50/
p65 and p50/p50 complexes persisted following incubation of
lysates from infected cells with p65 and p50 antibodies. The
precise nature of these complexes is presently unknown. The
results presented in Fig. 2A indicate that the absence of either
of the IKK catalytic subunits resulted in decreased levels of
nuclear NFB (p50/p65), consistent with their role in nuclear
translocation of p50/p65. Interestingly, the amounts of p50
homodimer activity increased in all three cell types following
HSV infection or TNF- treatment (see Fig. 2B for a better
example of p50 homodimer activity in WT cells). This latter
result suggests that the SCF()-TrCP ubiquitin ligase required
to initiate limited proteolysis of p105 to yield p50 is activated
following both TNF- treatment and HSV-1 infection (39).
FIG. 1. Both IKK and IKK contribute to the activation of NFB
in HSV-infected cells. Western blot analysis for proteins involved in
NFB activation (A) and for viral proteins (B and C) in murine cell
lines. Nuclear and cytoplasmic extracts were prepared from normal
(WT), IKKa/, IKKb/, p65/, and p65/ cells at 8 hpi, and they
were then probed for the indicated cellular and viral proteins as de-
scribed in Materials and Methods. M, mock infected; H, HSV infected;
T, TNF- treated. (B) Nuclear extracts were probed for ICP27 and
ICP8, while cytoplasmic extracts were probed for gC and VP16.
TABLE 1. Virus yield assays from normal, IKK/, and
IKK/ MEFsa
Cell type









Normal (3.86 	 1.5)  107 (3.74 	 0.36)  107
IKK/ (7.09 	 3.4)  106 5.4 (6.0 	 .37)  106 6.2
IKK/ (2.4 	 0.16)  106 16.3 (2.62 	 0.33)  106 28.5
a Cells and culture media from three independent experiments were collected
at the indicated times postinfection, and yields were determined as described in
Materials and Methods. Relative fold decrease is the ratio of yield on control
cells to knockout cells.
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IB contributes to efficient replication of HSV. NFB is
sequestered in the cytoplasm by IB. Following phosphoryla-
tion of IB at serine residues 32 and 36, which triggers its
polyubiquitylation and destruction by the 26S proteosome,
NFB translocates into the nucleus. DNIB, in which these
serines are mutated to alanines, is resistant to cytokine-in-
duced turnover, and p50/p65 is retained in the cytoplasm (42).
It was previously reported that infection of pooled clones of
C33-A cells stably expressing DNIB resulted in reduced nu-
clear translocation of NFB and reduced virus yield compared
to that of control cells (40). This experimental approach could
not control for variable expression of DNIB among individual
cells and could potentially accommodate some NFB activa-
tion and virus replication. We therefore employed infection
with an adenovirus vector to transiently express DNIB in all
cells in the culture. A549 cells were infected with an adenovirus
vector expressing GFP (Ad-eGFP) or with adenovirus express-
ing DNIB (Ad-DNIB), and after 16 h the cells were super-
infected with HSV for 8 h or were treated with TNF- for 15
min prior to harvest. Figure 3A represents Western blots for
IB in cytoplasmic extracts. Infection with HSV or treatment
with TNF- of cells infected with Ad-eGFP resulted in the
almost complete loss of endogenous IB (Fig. 3A, lanes 2 and
3). A 1.45-fold decrease in IB was detected in cells infected
with Ad-DNIB and superinfected with HSV, consistent with
loss of only the endogenous form of the protein. The total level
of IB present following TNF- treatment was unchanged
compared to that of mock treatment (Fig. 3A, compare lanes
4 and 6). Whether this reflected minimal loss of endogenous
IB following treatment is unclear, but analysis of nuclear
extracts by EMSA (Fig. 3B.) indicated efficient suppression of
NFB DNA-binding activity in cells infected with Ad-DNIB
(compare lanes 1 to 3 with lanes 4 to 6). The effect of DNIB
on viral gene expression was also analyzed. Lysates from con-
trol and DNIB lysates were probed for the DE protein ICP8
and the L protein gC and were quantified by Image J. While
there was a twofold decrease in the amount of ICP8, the level
of gC declined 6.5-fold in DNIB-expressing cells compared to
that in the control lysate. These results were reminiscent of
those presented in Fig. 1 for the effect on viral protein accu-
mulation in cells lacking IKK or IKK.
We then determined the effect of DNIB expression on
virus replication following a similar infection protocol. We
infected murine 3T3 cells and the human tumor cell lines A549
and Hep2 with Ad-DNIB, followed by HSV superinfection.
Production of progeny virus was determined by a plaque assay
on Vero cells, and the results are presented in Tables 2 and 3.
Two separate experiments involving murine fibroblasts were
performed. Infectious virus was assayed at 16 and 24 hpi fol-
lowing low-MOI (0.2) infection or at 20 hpi following infection
at an MOI of 0.2 or 1. Virus yields were reduced 
15- to
25-fold in DNIB-expressing cells compared to that of Ad-
eGFP control cells (Table 2). Following low-MOI (0.2) infec-
tion of A549 or Hep2 cells, virus yield was reduced to 1,300-
fold (Table 3). When the input MOI of A549 cells was
increased to 1, the fold decrease in virus yield was reduced
accordingly (42- to 62-fold) and still represented a significant
decrease of 18-fold even at an MOI of 5. Replication of HSV
in Hep2 cells was extremely sensitive to expression of DNIB.
Even at an MOI of 5, virus yield was reduced almost 800-fold
(Table 3).
FIG. 2. IKK and IKK contribute to NFB activation and effi-
cient replication in HSV-infected cells. (A) EMSA for NFB DNA-
binding activity in WT, IKKa/, and IKKb/ MEFs was performed
with extracts prepared from mock-infected cells (M), cells infected for
8 h with HSV (I), or cells treated for 15 min with TNF- (T). (B) Ex-
tracts prepared from WT MEFs treated for 15 min with TNF- or
infected for 8 h with HSV were incubated with antibody to NFB
subunits p50 or p65 or an irrelevant antibody against E2F4 prior to
incubation with the NFB-specific oligonucleotide. Filled circles to the
right of each lane identify supershifted complexes in response to in-
cubation with anti-p50 or anti-p65. For both panels, only the portion of
the autoradiograph containing specific complexes is shown.
FIG. 3. Characterization of cells expressing DNIB. (A) Western
blot for IB and viral proteins. Replicate cultures of A549 cells were
infected with a 100-ffu/cell concentration of adenovirus vector express-
ing enhanced GFP (Ad-eGFP) or DNIB (Ad-DNIB). After 16 h,
monolayers were mock infected (lanes 1 and 4), infected with HSV-1
at an MOI of 5 for 8 h (lanes 2 and 5), or treated with 50 ng of human
recombinant TNF-/ml (lanes 3 and 6) for 15 min prior to harvest.
Cytoplasmic lysates were prepared and analyzed for IB, gC, or
-tubulin by Western blot. Nuclear lysates were analyzed for ICP8.
(B) EMSA for NFB binding activity. Nuclear lysates were prepared
from A549 cells initially infected with either Ad-eGFP or Ad-DNIB,
and then they were either mock infected, infected with HSV-1, or
treated with TNF- as described for cultures analyzed in the experi-
ment presented in panel A. NS, nonspecific binding activity.
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PKR is not necessary for NFB activation in HSV-infected
cells. Because HSV induces IKK activity (1) and because IKK
and IKK both contribute to NFB activation by HSV-1 (Fig.
1 and 2), we next asked whether PKR, a stress- and virus-
induced kinase, is necessary for NFB activation and efficient
virus replication. The double-stranded RNA-activated protein
kinase, PKR, activates NFB by stimulating IKK activity and
inducing turnover of IB and IB (57), though it is not
known whether the critical serine residues on IB and IB
are phosphorylated (21, 33). In fibroblasts from PKR-deficient
(PKR0/0) mouse embryos, double-stranded RNA, alpha inter-
feron, and gamma interferon failed to activate NFB, while
TNF- still functioned as an inducer (57). PKR is known to be
activated with late kinetics in cells infected with WT HSV-1
and 1 34.5 mutants of HSV-1, but it is not known whether this
is via autophosphorylation or by a virus-encoded or -induced
kinase (8). PKR-dependent phosphorylation of eIF2 is re-
versed in virus-infected cells through the action of the 1 34.5
protein (16). Recently, NFB activation in HSV-infected cells
was reported to be dependent on PKR, based on infection of
PKR/ and PKR0/0 MEFs (43). MEFs from normal mice
(PKR/) or mice with a targeted deletion of PKR (PKR/)
(54) were infected with HSV, and virus yields at 16 and 24 hpi
were determined by plaque assay (Table 4). Virus yields from
PKR/ cells were similar at 16 h and were approximately
fourfold increased at 24 h relative to yields from PKR/ cells.
EMSA for NFB DNA-binding activity from nuclear extracts
of PKR/ and PKR/ cells are presented in Fig. 4A. Little
NFB activity was detectable in the extract from mock-infected
PKR/ cells, while both TNF- treatment and HSV infection
induced NFB activities consisting of p50/p65 or operationally
defined as p50 homodimer, based on effects of p65 and p50
antibodies on the mobility of the complexes (data not shown).
Mock-infected PKR/ cells constitutively expressed the p50
activity, which increased substantially following HSV infection
or TNF- treatment. HSV infection also induced p50/p65 ac-
tivity comparable to that seen in the PKR/ cells, while
TNF- induction was impaired. Finally, we asked whether the
absence of PKR affected the turnover of IB normally ob-
served after virus infection. Equivalent amounts of cell lysate
were separated by SDS-PAGE and probed by Western blot
(Fig. 4B). Amounts of IB were considerably reduced after
HSV infection of both PKR/ and PKR/ cells, while the
amount of ICP4 detected was greater in the PKR/ lysate.
Together, these results indicate that PKR is not essential for
HSV-induced NFB activation, but it does contribute to NFB
TABLE 2. Virus yield in WT MEFsa
Expression vector and expt no.














Ad-eGFP (HSV MOI  0.2) 1.4  107 2.5  107
Ad-DNIB (HSV MOI  0.2) 2.3  106 6 1.7  106 14.7
Expt 2
Ad-eGFP (HSV MOI  0.2) 1.95  107
Ad-DNIB (HSV MOI  0.2) 7.4  105 26.4
Ad-eGFP (HSV MOI  0.1) 3.7  107
Ad-DNIB (HSV MOI  0.1) 2.23  106 16.6
a Cells and culture media were collected at the indicated time points, and infectious titers were determined as described in Materials and Methods. Relative fold
increase in virus yield is the ratio of yield from control cultures to yield from DNIB-expressing cultures.
TABLE 3. Virus yield in A549 and Hep2 cells expressing DNIBa
Cell type, expression
vector, and expt no.















Ad-eGFP 4.1  108 4.1  108 4.5  108
Ad-DN-IB 4.1  106 100 9.8  106 41.8 2.4  107 18.4
Expt 2
Ad-eGFP 5.7  107 8.7  107 1.05  108
Ad-DN-IB 2.13  105 267 1.41  106 61.7 5.6  106 18.7
Hep2
Expt 1
Ad-eGFP 1.3  107 7.8  107 1.5  108
Ad-DN-IB 1  104 1,300 6.7  104 1,164 1.9  105 789
a Cells and culture medium were collected, and infectious titers were determined as described in Materials and Methods. Cultures were harvested at 24 hpi. Relative
fold decrease in virus yield is the ratio of yield from control cultures to yield from DN-IB expressing cultures. The analysis of virus yield in Hep2 cells was performed
once.
13586 GREGORY ET AL. J. VIROL.
activation by TNF-. It remains possible that PKR can have
offsetting effects on virus replication. For example, PKR may
contribute to NFB activation when present, but in its absence
the pathway leading to eIF2 phosphorylation is disrupted. At
this time we cannot rule out the possibility that the greatly
increased amount of p50 homodimer also contributes to effi-
cient virus replication (see Discussion). The basis for the dif-
ferences between our results and those previously published
(43) is unclear, though they could reflect differences in HSV
strain or the time of harvest postinfection.
NFB promotes an antiapoptotic response in HSV-infected
cells. HSV efficiently suppresses apoptosis (3, 4, 19, 24, 25, 62),
and one recent report pointed to activation of NFB as an
important mediator of this effect (15). NFB has a well-docu-
mented role in suppressing apoptosis under a variety of con-
ditions (5, 31, 48, 50). One way in which the NFB activation
pathway might be linked to enhanced virus yields would be
through the mechanism of apoptosis suppression. To test this
model we asked whether expression of DNIB eliminated apo-
ptosis suppression by HSV. We assayed for cell surface phos-
phoserine by staining with fluorochrome-conjugated Annexin
V and for cleavage of PARP (Fig. 5). Parallel cultures of Hep2
cells were infected with Ad-DNIB, followed at 16 h by super-
infection with HSV. Uninfected cultures or cultures receiving
Ad-DNIB but not superinfected with HSV served as controls,
and all cultures with HSV were harvested at 24 hpi. The frac-
tion of HSV-infected cells stained with Annexin V increased
from 
20 to 
43% by 24 hpi as the MOI of Ad-DNIB
increased from 0 to 200 focus-forming units (ffu)/cell (Fig. 5A).
By contrast, only 7% of cells infected with 300 ffu of Ad-
DNIB but not superinfected with HSV displayed cell surface
Annexin V staining. In a second experiment, we infected Hep2
cells with different amounts of Ad-DNIB, followed by mock
infection, infection with WT HSV-1, or infection with the
ICP27 mutant d27-1. The latter virus has been reported to
efficiently induce apoptosis in human cells (3, 4). Lysates were
prepared and assayed for PARP by Western blot, and the
results are shown in Fig. 5B. Whereas unprocessed (
116
kDa) PARP was present in all lysates, increased amounts of
processed PARP (85-kDa) were present in lysates of WT HSV-
infected cells only when DNIB was expressed (lanes 3 to 4) or
in lysates from all cultures infected with d27-1 (lanes 6 to 9).
DISCUSSION
Previous studies have described NFB activation after HSV
infection (1, 15, 40). Results of studies reported here extend
this observation, documenting the roles of upstream effectors
of NFB in this process as well as in efficient virus replication.
Specifically, IKK and IKK as well as IB are critical for
FIG. 4. PKR is not necessary for NFB activation in HSV-infected
cells. (A) EMSA for NFB was performed as described in Materials
and Methods with nuclear extracts prepared from mock-infected,
TNF--treated, or HSV-infected PKR/ and PKR/ MEFs.
(B) Western blot of IB and IE ICP4 was performed on whole-cell
extracts prepared from mock-infected (M) or HSV-infected
(I) PKR/ and PKR/ MEFs.
FIG. 5. NFB promotes an antiapoptotic response in HSV-in-
fected cells. (A) Replicate monolayers of Hep2 cells were infected with
an adenovirus vector expressing DNIB from a cytomegalovirus pro-
moter at the indicated MOI. After 24 h, monolayers were either mock
infected or infected with HSV at an MOI of 5. At 24 hpi cells were
harvested, stained for Annexin V, and processed for FACS analysis as
described in Materials and Methods. (B) Parallel cultures of Hep2
cells were infected with adenovirus vector expressing DNIB at the
indicated MOIs. After 24 h, monolayers were mock infected or in-
fected with WT HSV-1 or the ICP27 null mutant d27-1 at an MOI of
5. Whole-cell extracts were prepared at 24 hpi for Western blot anal-
ysis of PARP.
TABLE 4. Effect of loss of PKR on virus yielda
Cell type









PKR/ 1.65  107 2.2  107
PKR0/0 1.25  107 1.3 9.0  107 4
a Monolayers of PKR/ and PKR0/0 cells were infected with HSV at an MOI
of 5. Cells and culture media were collected at the indicated times postinfection,
and infectious titers were determined as described in Materials and Methods.
Virus yield on these cell types was analyzed once.
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efficient activation, as measured by nuclear localization of p65
and increases in nuclear NFB-dependent EMSA activity.
Though activated after HSV infection, no role for PKR in
NFB activation was observed. As measured by either accu-
mulation of specific viral proteins or production of infectious
virus, the intact IKK-IB-NFB pathway contributed to effi-
cient virus replication. This efficiency of virus replication may
in part reflect the suppression of apoptosis by a mechanism
requiring activation of the NFB. It was previously reported
(40) that nuclear translocation of NFB after HSV infection
was not accompanied by NFB-dependent promoter activa-
tion. Amici and coworkers (1) reported functional activation of
NFB after infection, and the work of Goodkin et al. (15) and
work presented here imply that NFB is functional and par-
ticipates in the program of apoptosis suppression following
virus infection. We attribute the previous inability to detect
NFB activity largely to the cell type (C33-A) and the chlor-
amphenicol acetyltransferase reporter used in previous studies.
We can readily detect functional NFB in HeLa and
HEK293T cells following infection by using a 3XNFkB lucif-
erase-based reporter (D. Hargett, J. Prince, and S. Bachenhei-
mer, unpublished observations).
The requirement for IKK in NFB activation during HSV
infection of murine fibroblasts largely mirrors its requirement
for activation by TNF-. Thus, loss of cytoplasmic IB and
nuclear accumulation of p65 were either modestly impaired
(IKKa/) or largely impaired (IKKb/) relative to normal
cells, and NFB-dependent EMSA activity was greatly re-
duced. It has been reported that IKK plays a critical role (27,
29), while IKK plays a redundant (18, 26, 45) or distinct (28,
41) role, in cytokine-mediated NFB activation in murine cells.
By using an RNA interference approach, both IKK catalytic
subunits were shown to play critical roles in cytokine-induced
NFB in human cells (44). Future experiments will be directed
at understanding whether a requirement for both IKK and
IKK also holds for NFB activation by HSV in human cells.
Both IKKa/ and IKKb/ cells supported comparable
amounts of IE ICP27 and DE ICP8 accumulation relative to
normal cells, but they had greatly reduced expression of L
proteins VP16 and gC. These results are consistent with the
reduced yield of infectious virus from these cell lines and with
previous reports on virus yield (1, 40).
Infection of murine fibroblasts deleted for PKR resulted in
NFB-dependent EMSA activity and yield of infectious virus
comparable to or greater than that seen following infection of
normal cells. We also noted constitutive expression of a p50
homodimer form of NFB and its substantial increase follow-
ing either TNF- treatment or HSV infection. While p50 ho-
modimers would not be expected to have transcriptional trans-
activation potential, Bcl-3, an IB family member, complexes
with and relocates p50 homodimers to the nucleus, where it
can also serve as a transcriptional coactivator of p50 ho-
modimers (9, 13). Thus, it remains possible that increased p50
homodimer formation in part mediates efficient HSV replica-
tion in PKR0/0 cells and that preventing p50/p65 activation by,
for example, ectopic expression of DNIB may not reduce
HSV replication.
HSV infection induces and then efficiently suppresses apo-
ptosis. Consistent with the role of NFB as a cell survival
factor, there is a strong correlation between the ability of HSV
to express functional ICP27 and the suppression of apoptosis
(3) and between expression of NFB and suppression of apo-
ptosis (15). Coupled with the requirement for functional ICP27
to activate NFB (D. Hargett and S. Bachenheimer, submitted
for publication), we propose that a delayed-type activation of
NFB, dependent on viral gene expression, plays an important
role in prolonging functional cell survival and, thus, efficient
virus replication. This delayed-type activation has also been
observed following infection of cells with human cytomegalo-
virus (HCMV) (55) and was termed second-tier activation.
Another mechanism of virus-induced NFB activation is in-
ferred from experiments which characterized the ability of
HSV-1 to both trigger and inhibit apoptosis (4, 25). A key
finding in the recognition of a rapid-type activation of NFB
stemmed from experiments which demonstrated that ectopic
expression of virion glycoproteins gD or gJ could rescue cells
from apoptosis following infection with virus deleted for the
gD gene (61, 62). Interestingly, the domains of gD involved in
blocking apoptosis for the most part do not overlap those
domains involved in binding HveC, the ubiquitously expressed
gD receptor (60). More recently, either infection with UV-
inactivated HSV or exposure of cells to gD was shown to
protect cells from Fas-mediated apoptosis by a mechanism that
was dependent on NFB activation (34). One inference that
could be drawn from both these experiments was that the
protective effect of gD occurred at the time of virus binding
and entry and, thus, did not have a requirement for de novo
viral gene expression. This situation is similar to that of the
first-tier activation of NFB observed during infection with
HCMV (56) and suggests that two mechanistically distinct
mechanisms of NFB activation occur during HSV infection.
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